News Conference News ESC 2024 Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events Caitlin E. Cox August 31, 2024
News Conference News ESC 2023 COP-AF: Colchicine Doesn’t Cut Post-Op AF or Myocardial Injury Michael O'Riordan August 25, 2023
News Conference News ESC 2022 COVID-PACT: Full-Dose Anticoagulation Improves Outcomes in Critical COVID-19 Todd Neale September 01, 2022
Presentation ESC 2022 Colchicine and Aspirin in Community Patients with COVID-19: An Open-label, Factorial, Randomized Trial Presenter: John Eikelboom August 29, 2022
Presentation ESC 2022 Colchicine and Rivaroxaban Plus Aspirin in Patients Hospitalized with COVID-19: A Factorial, Randomized, Open Trial Presenter: Sanjit Jolly August 28, 2022
News Conference News ESC 2021 New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy Michael O'Riordan September 03, 2021
News Daily News ESC 2021 Colchicine in STEMI Fails to Reduce Infarct Size: COVERT-MI Caitlin E. Cox August 26, 2021
News Conference News ESC 2020 LoDoCo2: Colchicine Protective in Large RCT of Chronic Coronary Disease Caitlin E. Cox August 31, 2020